Expanding the design space of cellular immunotherapy
Cellular states of dysfunction undermine CAR T effectiveness and are a prominent mechanism of treatment failure that could in theory be overcome by tuning therapeutic cell self-renewal and differentiation. Yet there are few static, irreversible genetic modifications that can safely manipulate these core cell fate dynamics. We are leveraging user-controlled, chemical biology approaches to hack the central cellular processes that determine therapeutic potential.